53312-78-0 Usage
Uses
Used in Pharmaceutical Industry:
3-Amino-5-chloro-benzonitrile is used as a key intermediate for the synthesis of new drugs and chemical compounds, contributing to the development of innovative treatments and therapies.
Used in Agrochemical Industry:
3-AMINO-5-CHLORO-BENZONITRILE is utilized as an intermediate in the production of agrochemicals, playing a role in the creation of substances that protect crops and enhance agricultural productivity.
Used in Dye and Pigment Industry:
3-Amino-5-chloro-benzonitrile is used as a building block in the synthesis of dyes and pigments, which are essential for coloring textiles, plastics, and other materials.
Used in Organic Synthesis:
As a reagent in organic chemical reactions, 3-amino-5-chloro-benzonitrile is employed to construct heterocyclic compounds, which are important in the development of various chemical products and pharmaceuticals.
Overall, 3-amino-5-chloro-benzonitrile is a significant component in the chemical industry, with applications spanning across multiple sectors due to its unique properties and synthetic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 53312-78-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,3,1 and 2 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 53312-78:
(7*5)+(6*3)+(5*3)+(4*1)+(3*2)+(2*7)+(1*8)=100
100 % 10 = 0
So 53312-78-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H5ClN2/c8-6-1-5(4-9)2-7(10)3-6/h1-3H,10H2
53312-78-0Relevant academic research and scientific papers
Aminoacetamide acyl guanidines as beta-secretase inhibitors
-
Page/Page column 17-18, (2008/06/13)
There is provided a series of substituted acyl guanidines of Formula (Ik) or a stereoisomer; or a pharmaceutically acceptable salt thereof, wherein R2, R3, R4, R5, R25, R26 and R27 as defined herein, their pharmaceutical compositions and methods of use. These compounds inhibit the processing of amyloid precursor protein (APP) by β-secretase and, more specifically, inhibit the production of Aβ-peptide. The present disclosure is directed to compounds useful in the treatment of neurological disorders related to β-amyloid production, such as Alzheimer's disease and other conditions affected by anti-amyloid activity.